ALKS Alkermes Plc.

$46.87 -1.81%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Alkermes Plc. (ALKS) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $7.9 billion. Shares last traded at $46.87, 15.8% below their 52-week high. Over the past year the stock is up 56.2%. ALKS trades at a price-to-earnings ratio of 118.90, above the Pharmaceutical Preparations median of 17.31. Net profit margin is 4.0%, above the peer median of -8.9%. Revenue declined 5.2% year over year.

Market Cap

$7.9B

Shares Out

167.8M

EPS (TTM)

$0.99

P/E Ratio

47.34

P/S Ratio

4.71

P/B Ratio

4.35

Dividend / Share

—

Dividend Yield

—

52-Week High

$55.64

52-Week Low

$25.16

Volume

62,434

Avg Vol (3m)

112,158.984

Performance

-4.18%

-5.55%

+8.06%

+65.48%

YTD

+65.86%

+56.16%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

39.10

SMA (50)

$50.72

SMA (200)

$37.63

Price vs SMA50

-7.59%

Price vs SMA200

+24.53%

ATR (14)

$2.26

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$1.7B

Net Income

$66M

Gross Margin

84.6%

Operating Margin

7.0%

Net Margin

4.0%

Return on Equity

3.7%

Return on Assets

1.5%

Current Ratio

2.30

Debt / Equity

0.84

Revenue Growth (YoY)

-5.2%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.40	2026-07-28
Q1 2026	$-0.40	2026-05-05
FY 2025	$1.43	2026-02-25
Q3 2025	$1.14	2025-10-28
Q2 2026	$0.65	2026-07-28
Q1 2026	$0.13	2026-05-05

Full earnings history →

Pharmaceutical Preparations peers

ALKS vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/E vs peers

118.90 / 17.31 med

+587% premium

P/S vs peers

4.71 / 11.11 med

-58% discount

Net margin vs peers

4.0% / -8.9% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.